Pacira Biosciences, Inc. (PCRX)
24.90
+0.82
(+3.41%)
USD |
NASDAQ |
Sep 16, 16:00
24.90
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Market Cap : 991.58M for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 958.92M |
| September 14, 2026 | 982.81M |
| September 11, 2026 | 1.010B |
| September 10, 2026 | 1.002B |
| September 09, 2026 | 1.031B |
| September 08, 2026 | 1.030B |
| September 04, 2026 | 1.049B |
| September 03, 2026 | 1.059B |
| September 02, 2026 | 1.058B |
| September 01, 2026 | 1.054B |
| August 31, 2026 | 1.031B |
| August 28, 2026 | 1.026B |
| August 27, 2026 | 1.029B |
| August 26, 2026 | 1.031B |
| August 25, 2026 | 1.017B |
| August 24, 2026 | 989.98M |
| August 21, 2026 | 982.42M |
| August 20, 2026 | 948.97M |
| August 19, 2026 | 970.07M |
| August 18, 2026 | 955.74M |
| August 17, 2026 | 925.47M |
| August 14, 2026 | 915.91M |
| August 13, 2026 | 923.08M |
| August 12, 2026 | 943.79M |
| August 11, 2026 | 970.87M |
| Date | Value |
|---|---|
| August 10, 2026 | 972.86M |
| August 07, 2026 | 996.35M |
| August 06, 2026 | 1.019B |
| August 05, 2026 | 990.38M |
| August 04, 2026 | 1.100B |
| August 03, 2026 | 1.072B |
| July 31, 2026 | 1.038B |
| July 30, 2026 | 1.060B |
| July 29, 2026 | 1.038B |
| July 28, 2026 | 1.054B |
| July 27, 2026 | 1.041B |
| July 24, 2026 | 1.017B |
| July 23, 2026 | 1.019B |
| July 22, 2026 | 1.006B |
| July 21, 2026 | 1.013B |
| July 20, 2026 | 996.50M |
| July 17, 2026 | 1.007B |
| July 16, 2026 | 1.006B |
| July 15, 2026 | 995.71M |
| July 14, 2026 | 983.13M |
| July 13, 2026 | 1.004B |
| July 10, 2026 | 1.002B |
| July 09, 2026 | 1.002B |
| July 08, 2026 | 1.003B |
| July 07, 2026 | 1.015B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Zimmer Biomet Holdings, Inc. | 18.46B |
| Liquidia Corp. | 6.100B |
| Johnson & Johnson | 643.91B |
| Merck & Co., Inc. | 357.83B |
| ANI Pharmaceuticals, Inc. | 1.691B |
Market Cap Related Metrics
| PE Ratio | 71.74 |
| PS Ratio | 1.407 |
| Price to Book Value | 1.476 |
| Price to Free Cash Flow | 5.848 |
| Price | 24.90 |
| Earnings Yield | 1.39% |
| Operating PE Ratio | 38.00 |
| Normalized PE Ratio | 51.11 |